EGFR mutation testing of lung cancer patients - Experiences from Vestfold Hospital Trust.

DISCUSSION: Especially for patients with advanced stages of NSCLC, EGFR mutation status is necessary for treatment stratification. Our results show that the guidelines were followed increasingly over time for patients diagnosed with NSCLC at the Vestfold Hospital Trust. The establishment of interdisciplinary meetings has improved the diagnostic routines.
PMID: 26313507 [PubMed - as supplied by publisher]

Source: Acta Oncologica - August 27, 2015 Category: Cancer & Oncology Authors: Berg J, Fjellbirkeland L, Suhrke P, Jebsen P, Lund-Iversen M, Kleinberg L, Helgeland L, Brustugun OT, Helland Å Tags: Acta Oncol Source Type: research